Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology

M. Humbert
European Respiratory Review 2010 19: 59-63; DOI: 10.1183/09059180.00007309
M. Humbert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    The key pathways and classes of drugs that have been approved for the treatment of pulmonary arterial hypertension. These may also have benefits in patients with chronic thromboembolic pulmonary hypertension, although further research is necessary to establish this. NO: nitric oxide; sGC: soluble guanylate cyclise; cGMP: cyclic guanosine monophosphate; COX: cyclo-oxygenase; NOS: NO synthase; ECE: endothelin converting enzyme; AC: adenylate cyclase; cAMP: cyclic adenosine monophosphate; ET: endothelin; GMP: guanosine monophosphate; PDE: phosphodiesterase; PH: pulmonary hypertension. Reproduced from [13] with permission from the publisher.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    The embolic hypothesis of chronic thromboembolic pulmonary hypertension (CTEPH). VTE: venous thromboembolism; PE: pulmonary embolism.

PreviousNext
Back to top
View this article with LENS
Vol 19 Issue 115 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
M. Humbert
European Respiratory Review Mar 2010, 19 (115) 59-63; DOI: 10.1183/09059180.00007309

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
M. Humbert
European Respiratory Review Mar 2010, 19 (115) 59-63; DOI: 10.1183/09059180.00007309
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • PAH
    • CTEPH
    • CONCLUSIONS
    • Statement of interest
    • Provenance
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Mucolytics for acute exacerbations of COPD: a meta-analysis
  • Targeting IL-33 and TSLP pathways for novel pulmonary therapeutics
  • Physical activity promotion interventions in chronic airways disease
Show more Reviews

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2023 by the European Respiratory Society